KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 153 filers reported holding KRYSTAL BIOTECH INC in Q3 2022. The put-call ratio across all filers is 3.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $945,195 | +5.4% | 5,147 | +2.1% | 0.01% | 0.0% |
| Q1 2024 | $896,589 | +42.1% | 5,039 | -0.9% | 0.01% | +20.0% |
| Q4 2023 | $631,093 | +6.8% | 5,087 | -0.2% | 0.01% | 0.0% |
| Q3 2023 | $591,136 | -7.3% | 5,096 | -6.2% | 0.01% | 0.0% |
| Q2 2023 | $637,717 | +52.5% | 5,432 | +4.0% | 0.01% | +25.0% |
| Q1 2023 | $418,073 | +4.1% | 5,222 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $401,566 | +18.1% | 5,069 | +4.0% | 0.00% | 0.0% |
| Q3 2022 | $340,000 | +9.7% | 4,876 | +3.3% | 0.00% | +33.3% |
| Q2 2022 | $310,000 | -1.3% | 4,718 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $314,000 | +15.4% | 4,712 | +21.3% | 0.00% | +50.0% |
| Q4 2021 | $272,000 | +32.7% | 3,885 | -1.2% | 0.00% | 0.0% |
| Q3 2021 | $205,000 | -22.1% | 3,931 | +1.5% | 0.00% | 0.0% |
| Q2 2021 | $263,000 | -8.4% | 3,873 | +3.9% | 0.00% | -33.3% |
| Q1 2021 | $287,000 | +29.3% | 3,729 | +0.6% | 0.00% | +50.0% |
| Q4 2020 | $222,000 | – | 3,706 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $38,530,000 | 3.46% |
| S Squared Technology, LLC | 80,215 | $3,453,000 | 2.57% |
| First Light Asset Management, LLC | 464,663 | $20,004,000 | 2.05% |
| Redmile Group, LLC | 1,501,945 | $64,659,000 | 1.19% |
| Nicholas Investment Partners, LP | 222,422 | $9,575,000 | 1.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 184,573 | $7,946,000 | 0.78% |
| HighMark Wealth Management LLC | 18,894 | $813,000 | 0.73% |
| Hood River Capital Management LLC | 257,203 | $11,073,000 | 0.48% |
| GARNET EQUITY CAPITAL HOLDINGS, INC. | 40,000 | $1,722,000 | 0.35% |
| Artal Group S.A. | 237,500 | $10,224,000 | 0.25% |